Anat Ashkenazi concluded her 23-year career at Eli Lilly and Co. on a high note. She served as the pharmaceutical firm’s CFO as it earned record revenue of $34 billion in 2023 amid booming sales ...

On Tuesday, Porat's successor, Anat Ashkenazi, made her earnings call debut ... who previously spent 23 years at drugmaker ...

One of the highlights of Eli Lilly's third-quarter results ... with fewer than 10% switching from Trulicity, said Lilly's chief financial officer Anat Ashkenazi on the call. Now, Lilly's focus ...

By Yuvraj Malik and Bhanvi Satija (Reuters) -Alphabet named Anat Ashkenazi as its chief financial officer on Wednesday, turning to a top executive from drugmaker Eli Lilly... INDIANAPOLIS - Eli ...

On Tuesday, Porat's successor, Anat Ashkenazi, made her earnings call ... who previously spent 23 years at drugmaker Eli Lilly, said on the call. "But I think any organization can always push ...